| Line Item | 2025-09-27 | Y/Y |
|---|---|---|
| Revenue | $2.25B | +25.7% |
| Cost of Revenue | $1.82B | +18.3% |
| Gross Profit | $422.6M | +72.0% |
| R&D Expense | $216.0M | +24.5% |
| SG&A Expense | $298.7M | +58.1% |
| Operating Income | -$115.0M | +1.5% |
| Pre-tax Income | -$78.9M | +0.9% |
| Income Tax | -$1.6M | -138.6% |
| Net Income | -$16.9M |
| Line Item | 2025-09-27 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.24B | +71.2% |
| Accounts Receivable | $186.7M | -7.4% |
| Inventory | $164.4M | +54.9% |
| Current Assets | $1.89B | +39.5% |
| Total Assets | $2.40B | +52.1% |
| Current Liabilities | $1.73B | +70.0% |
| Total Liabilities | $1.92B | +61.4% |
| Line Item | 2025-09-27 | Y/Y |
|---|---|---|
| Operating Cash Flow | $866.9M | +1592.7% |
| Investing Cash Flow | -$350.7M | -324.1% |
| Financing Cash Flow | $668K | -99.8% |
| -25.6% |
| EPS (Basic) | -$0.16 | -14.3% |
| EPS (Diluted) | -$0.16 | -14.3% |
| Stockholders' Equity |
| $221.3M |
| +12.2% |